Out-licencing
Available dossiers
API |
Strength |
Formulation |
|
Alendronate*
|
70mg
|
tablets
|
| Doxylamine | 15mg, 25mg | tablets |
| Enalapril + HCTZ* | 20mg + 12,5mg | tablets |
|
Indapamide
|
1.5mg
|
SR tablets
|
|
Irbesartan**
|
75mg, 150mg, 300mg
|
tablets
|
| Irbesartan** + HCTZ* | 150mg + 12,5mg, 300mg + 12,5mg | tablets |
|
Meloxicam
|
15mg/1.5ml
|
injection
|
|
Montelukast sodium**
|
10mg
|
tablets
|
|
Montelukast sodium**
|
4mg, 5mg
|
chewing tablets
|
|
Olanzapine
|
5mg, 7.5mg, 10mg
|
film-coated tablets
|
|
Olanzapine
|
15mg, 20mg
|
tablets
|
|
Olanzapine ODT
|
5mg, 10mg, 15mg, 20mg
|
tablets
|
| Orlistat** | 120mg | capsules |
|
Perindopril
|
4mg, 8mg
|
tablets
|
|
Piracetam
(dossier available in Polish) |
3g / 15ml
|
injection
|
|
Quetiapine
|
25mg, 100mg, 150mg, 200mg, 300mg
|
tablets
|
|
Topiramate**
|
25mg, 50mg, 100mg, 200mg
|
tablets
|
| Tramadol/Paracetamol | 37,5mg / 325mg | tablets |
|
Sildenafil citrate*
|
25mg, 50mg, 100mg
|
film-coated tablets
|
|
Sumatriptan
|
50mg, 100mg
|
film-coated tablets
|
|
Valsartan**
|
80mg, 160mg
|
tablets
|
| Valsartan + HCTZ* | 80mg + 12,5mg, 160mg + 12,5mg, 160mg + 25mg | tablets |
* based on API from Polpharma Fine Chemicals Business Unit
** dossier based on API from first supplier, API from Polpharma Fine Chemicals Business Unit will be registered as a second supplier later
/userfiles/images/banner-cphi_worldwide-1-visit-us-at-stand-6f57.gif)